Insider Shareholders with Direct Ownership of Turning Point Therapeutics, Inc. (TPTX)
This section provides a comprehensive overview of the insiders with direct ownership of Turning Point Therapeutics, Inc. (TPTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Turning Point Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Andrew John Partridge
EVP & Chief Commercial Officer |
39,919 | 2,090 | 22,078 $0 | 5 |
Feb 09, 2022
Reduced 0.99%
|
|
Annette North
EVP & General Counsel |
98,648 | 70,669 | 11,696 $0 | 14 |
Feb 09, 2022
Reduced 5.41%
|
|
Yi Larson
EVP & Chief Financial Officer |
36,839 | 30,000 | 7,321 $0 | 6 |
Feb 08, 2021
Added 38.67%
|
|
Brian Lee Baker
SVP of Finance and Admin. |
62,997 | 59,673 | 4,116 $0 | 8 |
Mar 23, 2021
Reduced 2.37%
|
|
Siegfried Reich
EVP & Chief Scientific Officer |
52,962 | 35,947 | 3,448 $0 | 5 |
Feb 09, 2022
Reduced 10.33%
|
|
Paolo Tombesi
EVP & Chief Financial Officer |
29,883 | 30,961 | 0 $0 | 4 |
Aug 17, 2022
Reduced 100.0%
|
|
Steve M Sabus
SVP & Chief Commercial Officer |
36,667 | 36,667 | 0 $0 | 2 |
Aug 17, 2022
Reduced 100.0%
|
|
Brian Sun
SVP & General Counsel |
45,000 | 45,000 | 0 $0 | 2 |
Aug 17, 2022
Reduced 100.0%
|
|
Mohammad Hirmand
EVP and Chief Medical Officer |
50,466 | 52,253 | 0 $0 | 8 |
Aug 17, 2022
Reduced 100.0%
|
|
Athena Countouriotis
President & CEO |
171,889 | 173,930 | 0 $0 | 14 |
Aug 17, 2022
Reduced 100.0%
|
|
Mark J Alles
Director |
2,000 | 2,000 | 0 $0 | 2 |
Aug 17, 2022
Reduced 100.0%
|